NovaDigm Therapeutics
A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease
1
Funding Rounds
$14.0m
Money raised
Overview
A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease
- Website:
- Business model: B2C B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Br** Sp******* | - | - | - |
| Sc*** G. Fi**** | - | - | - |
| Yu* Fu | - | - | - |
| As**** S. Ib***** | - | - | - |
| Mi***** R. Ye**** | - | - | - |
| Jo** E. �******** Ed***** | - | - | - |
Funding series
Funding Series Analysis
The company NovaDigm Therapeutics has raised a total of $14m in funding over 1 rounds.
Key Insights:
- NovaDigm Therapeutics Series B round: $14m
NovaDigm Therapeutics Series B round
$14m
Industries
NovaDigm Therapeutics is active in the following industries: